Alternatives to Davinci Neuroscience

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Global biotechnology company pioneering innovative medicines for complex neurological, neuropsychiatric, and rare diseases.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Develops a platform for adaptive clinical trial design and closed-loop execution.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Omec.ai is a life sciences startup focused on accelerating drug discovery and development through AI.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

AI-driven platform for protein-level disease mapping and drug discovery.

Omnix Medical is developing a novel platform for advanced wound care management.

Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

Biotechnology company developing potentially curative cell therapies for cancer patients.

Biotech company developing next-generation immunotherapy agents to unlock the immune system.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Genocure AI is developing AI-powered solutions for oncology drug discovery and development.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Cloud-based platform for reproducible computational research in life sciences.

Biopharmaceutical company developing human haploid stem cells for regenerative medicine and disease therapy.

Biotech developing novel technologies to restore physiological balance in apoptosis-related diseases.

EU-based company providing personalized medicine solutions for medical practitioners.

Biomica is developing a novel microbiome-based platform for the treatment of cancer.

Developing novel therapeutic approaches for ocular diseases.

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

Develops and launches Padeliporfin VTP therapy for solid tumor treatment.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Clinical-stage biotech developing novel therapeutics for hematological malignancies and disorders.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

AI-powered digital platform for life sciences, accelerating clinical research and drug development.

AI-driven digital twin of embryo development for cell-based therapies.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Biopharmaceutical company developing targeted neutrophil nanoparticle platform for chronic diseases.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Developing topical treatments to prevent and treat skin toxicities from cancer therapies.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

Developing universal donor-free red blood cells for life-saving transfusions and advanced therapies.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Biotechnology company developing novel therapies for multiple myeloma.

AI-powered blood test for early cancer detection and subtyping.

Own Chemex.ai today. Secure checkout and guided transfer support. No hidden fees.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Develops a platform for individual drug customization using aptamers for cancer treatment.

Compressing biology to develop the next generation of therapies.

AI-powered insights platform for life sciences and biotech workflows.

Galimedix Therapeutics is a clinical-stage biopharmaceutical company developing novel radiopharmaceuticals for PET imaging.

Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology.

Developing novel therapeutics targeting the tumor microenvironment for cancer treatment.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.